Agent: Tragara Pharmaceuticals, Inc.20110301210 - Use of pramipexole to treat amyotrophic lateral sclerosis: The present invention is directed to compositions comprising pramipexole and the use of such compositions to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS).